An optimized system for genome-wide CRISPR screens identifies in vivo dependencies in pancreatic cancer | Research Institute of Molecular Pathology (IMP)

An optimized system for genome-wide CRISPR screens identifies in vivo dependencies in pancreatic cancer

18 September 2024
14:00
GMI Orange Seminar Room
Vivien Vogt

Institute:: IMP - Zuber Lab
Type:: PhD Defense
Location:: GMI Orange Seminar Room

Share

Facebook Twitter Google Plus LinkedIn